prof. dr. apr. Jan Van Bocxlaer
- ORCID iD
-
0000-0002-4505-5510
Show
Sort by
-
- Journal Article
- A1
- open access
Building Sub-Saharan African PBPK populations reveals critical data gaps : a case study on Aflatoxin B1
-
Developing evidence-based dosing recommendations for intravenous ciprofloxacin in critically ill children: a population pharmacokinetic study using total and unbound concentrations
-
Synergy of body composition, exercise oncology, and pharmacokinetics : a narrative review of personalizing paclitaxel treatment for breast cancer
-
- Journal Article
- A1
- open access
Dose-limiting toxicities of paclitaxel in breast cancer patients : studying interactions between pharmacokinetics, physical activity, and body composition : a protocol for an observational cohort study
-
- Journal Article
- A1
- open access
Penetration of antibiotics into subcutaneous and intramuscular interstitial fluid : a meta-analysis of microdialysis studies in adults
-
Unlocking diversity : towards a comprehensive framework for physiologically based pharmacokinetic population qualification in Sub Saharan Africa
-
- Journal Article
- A1
- open access
Exploring the impact of efavirenz on aflatoxin B1 metabolism : insights from a physiologically based pharmacokinetic model and a human liver microsome study
-
Development and validation of an UPLC-MS/MS method for the determination of irinotecan (CPT-11), SN-38 and SN-38 glucuronide in human plasma and peritoneal tumor tissue from patients with peritoneal carcinomatosis
-
Population pharmacokinetics of lisinopril in hypertensive children and adolescents with normal to mildly reduced kidney function
-
Building a physiologically-based pharmacokinetic model for a carcinogenic food contaminant aflatoxin B1